Pharma channel feed – Endpoints News

Pharma channel feed

Arrowhead shelves one cardiometabolic drug candidate, focuses on another

10 months ago

Lilly becomes the latest pharma to tap OpenAI for help, this time for antibiotic work

10 months ago

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

10 months ago

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

10 months ago

Teva to pay $750M to resolve Israel tax disputes

10 months ago

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

10 months ago

FDA again rejects AbbVie's continuous infusion therapy for Parkinson's

10 months ago

J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded

10 months ago

Korea-based Bridge Biotherapeutics closes Boston office

10 months ago

Phase 3 breast cancer failure leads to staff cuts, stock drop at G1 Therapeutics

10 months ago

UK taps Pfizer over hometown GSK to supply RSV vaccine doses

10 months ago

Argenx wins second FDA approval for Vyvgart in autoimmune nerve disease

10 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

10 months ago

Bristol Myers wins approval for KRAS drug Krazati in colorectal cancer

10 months ago

FDA widens Sarepta’s Duchenne gene therapy label to older boys in significant expansion of use

11 months ago

Zealand Pharma hits early efficacy goal for amylin weight loss candidate

11 months ago

FDA to pharma companies: Using CRO Synapse's studies 'unacceptable'

11 months ago

CBER chief floats rare disease hub to better communicate across centers

11 months ago

Corrected: Emergent sells Baltimore facility for $30M

11 months ago

AbbVie adds ulcerative colitis to Skyrizi label

11 months ago

International society criticizes Utah law for permitting unapproved stem cell therapies

11 months ago

FDA loosens side effect reporting requirements for some CAR-T therapies

11 months ago

FTC backs plan to target more patent settlements it sees as anticompetitive

11 months ago

Teva and US government discuss settling kickback lawsuit over Copaxone

11 months ago

First page Previous page 47 48 495051 52 53 Next page Last page